Artemis Wealth Advisors, LLC Astrazeneca PLC Transaction History

Artemis Wealth Advisors, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Aug 21, 2023	BUY	$55.72 - $67.12 $72,436 - $87,256	1,300 New	1,300 $86,000
Q1 2022 Apr 22, 2022	BUY	$55.72 - $67.12 $72,436 - $87,256	1,300 New	1,300 $86,000
Q3 2021 Sep 11, 2023	BUY	$55.56 - $60.79 $555 - $607	10 Added 0.79%	1,281 $76,000
Q3 2021 Feb 17, 2023	BUY	$55.56 - $60.79 $555 - $607	10 Added 0.79%	1,281 $77,000
Q1 2021 Sep 11, 2023	BUY	$47.16 - $54.44 $59,940 - $69,193	1,271 New	1,271 $63,000
Q1 2021 Feb 17, 2023	BUY	$47.16 - $54.44 $1,131 - $1,306	24 Added 1.92%	1,271 $63,000
Q3 2020 Sep 05, 2023	BUY	$53.07 - $61.1 $530 - $611	10 Added 0.81%	1,247 $68,000
Q3 2020 Feb 17, 2023	BUY	$53.07 - $61.1 $530 - $611	10 Added 0.81%	1,247 $68,000
Q1 2020 Sep 05, 2023	BUY	$37.79 - $51.33 $46,746 - $63,495	1,237 New	1,237 $55,000
Q1 2020 Feb 17, 2023	BUY	$37.79 - $51.33 $46,746 - $63,495	1,237 New	1,237 $55,000
Q4 2019 Sep 01, 2023	BUY	$42.46 - $50.46 $52,523 - $62,419	1,237 New	1,237 $61,000
Q4 2019 Feb 13, 2023	BUY	$42.46 - $50.46 $52,523 - $62,419	1,237 New	1,237 $62,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Artemis Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Artemis Wealth Advisors, LLC with notifications on news.